1. Preparation

Feel free to contact us (preferably by phone) and we will make an appointment for a consultation. Important: you (i.e. the patient) have to come to the clinic in person and bring along photocopies of all your conventional medical records. It is not enough to send the documents by email alone. We charge a fee of €65 for this detailed initial consultation.

Your cancer situation is discussed in detail in the initial consultation. Should this result in the need for further examinations, they will be conducted by Prof. Dr. Maar. For example, a more precise localisation of metastases and their spreading may be required by F-choline PET-CT.

After this first exploratory consultation, you can calmly consider whether to take the proposed treatment. The duration and cost of the therapy will have been clarified and you will have been told that “day clinic” means that rest periods are provided for and that you will receive daily treatments over a longer period of time.
For legal reasons, you (i.e. the patient) will sign a detailed treatment contract. The treatment may of course be interrupted or terminated prematurely at any time after signing. A fee agreement must be signed separately from the treatment contract.

2. Treatment

Patients travelling from a distant location have to arrange for accommodation during the treatment period – and we are happy to help you with this. Pyjamas and various bath towels should be brought along for the treatment itself. Depending on the severity of the disease, you should be prepared for a treatment period of 2 to 6 weeks. Treatment takes place Monday to Friday for about 5 hours each day. You may be treated at weekends in exceptional cases. The treatment is an intensive therapy.

For detailed information on the actual treatment, see “Our treatment concept”.

3. Formal conditions

For privately insured patients or members of Beihilfekassen (medical insurance companies for civil servants, judges, etc), Prof. Maar writes a detailed ‘absorption of costs’ application to the medical insurance companies. Experience shows that the Beihilfekassen and private insurance companies accept the entire cost of treatment including all required medications. Recent case law and information from medical lawyers shows that private medical insurance companies and Beihilfekassen are legally obliged to pay for the cost of complementary therapy. We can help you with legal assistance and/or information on policy judgments regarding the financing of this therapy.

At the beginning of treatment, you will sign a detailed treatment contract, which provides information on cost, duration of treatment and the type of invoicing. You will be billed on weekly basis.

4. Following therapy

Following the first prolonged intensive therapy phase, a final consultation takes place; we will provide you with photocopies of all the points.

They will contain arrangements for further medicinal therapy and further conventional medical, radiological and laboratory-based control examinations (in this context, incidentally, we often notice how little organised oncology aftercare (tumor aftercare) many patients are provided with).

After talking about any open issues, we use this final consultation to discuss the possibility of or need for interval therapy (repeated therapy). It takes less time and has the important objective of boosting an immune system that is always getting worn down again, thus preventing the risk of further metastasis. This interval therapy is also dependent on the result of the control examinations after the first intensive therapy (e.g., behaviour of primary tumor or metastases). This interval therapy can be repeated several times. The initial extended treatment can also be repeated after a certain period.

5. Concluding remarks

The intensive therapy by Maar combines many or almost all plausible modes of action into a complementary, interlocking and complex mechanism. According to many patients, this therapy truly deserves the name “intensive therapy”.

The therapy has four objectives:
• strategic strengthening of the immune system
• destruction or destabilisation of tumor cells in the primary tumors, the cells of the metastases and, above all, the micro-metastases.
• prevention of recurrences
• improvement of the general health condition